首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 癌症 > 中國膀胱癌治療藥市場
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

中國膀胱癌治療藥市場

Chinese Markets for Bladder Cancer Treatment

出版商 Asia Market Information & Development Co.
出版日期 2009年09月 商品編碼 100203
內容資訊 英文 200 Pages
價格
US $ 4000 PDF by E-mail (Single User License)
US $ 8000 PDF by E-mail (Corporate Use License)


中國膀胱癌治療藥市場 是由出版商Asia Market Information & Development Co.在2009年09月所出版的。 這份英文市場調查報告書包含200 Pages 價格從美金4000起跳。

簡介

過去10年當中,中國的膀胱癌治療藥需求快速增加。未來5年內生產和需求量可望同時增加。

本報告書內容包括:中國的經濟動向、投資環境、產業發展及供需動向、行銷通路及主要進入市場企業介紹、2013年至2018年的長期預測等。內容綱要摘記如下:

第1章 介紹

  • 本調查報告的調查範圍及方法論
  • 實施概要

第2章 商業環境

  • 經濟預測
  • 金融及稅金規定

第3章 膀胱癌治療藥的產業評價

  • 產業結構
  • 市場規模
  • 市場成長促進因素
  • 銷售量
  • 主要製造商據點
  • 主要製造商的銷售量及市場佔有率
  • 人事費用
  • 潛在進入市場的企業
  • 主要物流業者
  • 主要海外資本
  • 技術開發

第4章 膀胱癌治療藥的生產及需求

  • 膀胱癌概要
  • 膀胱癌治療藥市場概要
  • 膀胱癌治療藥市場概要:分類別
  • 膀胱癌治療藥進出口:分類別
  • 市場概要:有效成分別
  • 市場概要:製造商別
  • 價格動向

第5章 市場預測

  • 市場預測
  • 政府規定
  • 醫療保險產業概要
  • 消費者支出動向
  • 人口統計動向
  • 醫療產業動向
  • 醫院及病床
  • 醫師及醫師訪問

第6章 行銷策略

  • 中國市場進入概要
  • 中國的流通系統
  • 膀胱癌治療藥通路
  • 運輸及交通建設
  • 通訊
  • 進入中國市場
  • 對中國出口
  • 間接出口
  • 直接出口
  • 授權及簽約生產
  • 中國國内組裝
  • 簽約生產
  • 貿易許可
  • 投資
  • 資本合作
  • 合併企業
  • 外資企業

第7章 膀胱癌治療藥製造商指南

  • 製造商介紹

圖表一覽

目錄

Abstract

China' s demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled

Table of Contents

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
    • Key Economic Indicators
    • Industrial Output
    • Population and Labor
    • Foreign Investment
    • Foreign Trade
  • Financial and Tax Regulations
    • Banking System and Regulations
    • Foreign Exchange
    • Taxes, Tariff and Custom Duties

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Bladder Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Bladder Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers' Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Overview
  • Bladder Cancer Treatment Drugs Market Overview
  • Bladder Cancer Treatment Drugs Market Overview by Classification
    • Intraluminal Perfusion Agents
  • Unilateral Chemotherapy Drug
  • First-line Chemotherapy Drug
    • Immunomodulator
  • Other Drugs
    • Bladder Cancer Treatment Drugs Import and Export by Classification
      • Bladder Cancer Treatment Drugs Import
      • Bladder Cancer Treatment Drugs Export
  • Market Overview by Drug' s Active Principle
  • Market Overview by Producers
  • Pricing Trend

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Bladder Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

VI. MARKETING STRATEGIES

  • China Market Entry Overview
  • China' s Distribution System
  • Bladder Cancer Treatment Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China' s Market Entry
  • Export to China
  • Indirect export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise

VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

  • Profiles of Bladder Cancer Treatment Drugs Producers

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share in 2008
  • Bladder Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their Market Share in 2008
  • Major Foreign Investment in China

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Treatment Drugs Import by Country in 2008
  • Bladder Cancer Treatment Drugs Export by Country in 2008
  • Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Bladder Cancer Treatment Drugs Import by Drugs Classification
  • Bladder Cancer Treatment Drugs Export by Drugs Classification
  • Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market Share in 2008
  • Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share in 2008
  • Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share in 2008

V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK

  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Bladder Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China' s GDP and Growth Rate
  • Industrial Output by Ownership
  • China' s Imports and Exports

III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

  • Bladder Cancer Treatment Drugs Sales Volume
  • Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification in 2008
  • Top 14 Bladder Cancer Treatment Drugs Market Share in 2008

IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

  • Bladder Cancer Treatment Drugs Sales Volume
  • Bladder Cancer Treatment Drugs Import
  • Bladder Cancer Treatment Drugs Import by Country in 2008
  • Bladder Cancer Treatment Drugs Export
  • Bladder Cancer Treatment Drugs Export by Country in 2008
  • Bladder Cancer Treatment Drugs Sales Volume by Classification in 2008
  • Intraluminal Perfusion Agents Sales Volume and Market Share
  • Unilateral Chemotherapy Drug Sales Volume and Market Share
  • First-Line Chemotherapy Drug Sales Volume and Market Share
  • Immunomodulator Sales Volume and Market Share
  • Other Drugs Sales Volume and Market Share
  • Bladder Cancer Treatment Drugs Import by Classification in 2008
  • Unilateral Chemotherapy Drug Import and Market Share
  • First-Line Chemotherapy Drug Import and Market Share
  • Intraluminal Perfusion Agents Import and Market Share
  • Immunomodulator Import and Market Share
  • Other Drugs Import and Market Share
  • Bladder Cancer Treatment Drugs Export by Drugs Classification in 2008
  • Unilateral Chemotherapy Drug Export and Market Share
  • First-Line Chemotherapy Drug Export and Market Share
  • Intraluminal Perfusion Agents Export and Market Share
  • Immunomodulator Export and Market Share

VI. MARKETING STRATEGIES

  • China' s Dist
Back to Top